Skip to main content
Fig. 3 | Virology Journal

Fig. 3

From: Salvage therapy with an Albuvirtide-based antiretroviral regimen for multi-drug resistant HIV and drug-resistant HBV with renal impairment: a case report

Fig. 3

Longitudinal Monitoring of HBV DNA Levels. Changes in HBV DNA levels (IU/ml) are tracked from 2007 to 2023. The vertical dashed line indicates the initiation of ABT therapy in March 2019. The figure demonstrates periods of viral suppression and a notable peak in viral load, followed by successful suppression after treatment adjustments

Back to article page

Virology Journal

ISSN: 1743-422X